APA (7th ed.) Citation

Grasselli, J., Elez, E., Caratù, G., Matito, J., Santos, C., Macarulla, T., . . . Azuara, D. (2017). Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer. Annals of Oncology, 28(6), 1294. https://doi.org/10.1093/annonc/mdx112

Chicago Style (17th ed.) Citation

Grasselli, J., et al. "Concordance of Blood- and Tumor-based Detection of RAS Mutations to Guide Anti-EGFR Therapy in Metastatic Colorectal Cancer." Annals of Oncology 28, no. 6 (2017): 1294. https://doi.org/10.1093/annonc/mdx112.

MLA (9th ed.) Citation

Grasselli, J., et al. "Concordance of Blood- and Tumor-based Detection of RAS Mutations to Guide Anti-EGFR Therapy in Metastatic Colorectal Cancer." Annals of Oncology, vol. 28, no. 6, 2017, p. 1294, https://doi.org/10.1093/annonc/mdx112.